Clinical Trial Update: Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas [Phase 2]

View source ↗

Summary

A Phase 2 trial of Cvac as maintenance therapy for patients with resected Stage I or Stage II pancreatic adenocarcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Cvac

Snippet

Sponsor: Prima BioMed Ltd | Conditions: Pancreatic Carcinoma Stage I, Pancreatic Carcinoma Stage II | Phase 2 | Status: WITHDRAWN